Jeff Yass’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-27,900
Closed -$736K – 14709
2026
Q2
$736K Buy
27,900
+12,200
+78% +$282K ﹤0.01% 8980
2026
Q1
$353K Buy
+15,700
New +$291K ﹤0.01% 10508
2025
Q1
– Sell
-41,500
Closed -$176K – 13610
2024
Q4
$176K Buy
+41,500
New +$259K ﹤0.01% 10868

Other funds holding ANRO

Jeff Yass's ANRO Position: Q3 2026 in Review

Jeff Yass increased its Alto Neuroscience (ANRO) stake by 944% in Q3 2026, buying an estimated $2.27M and bringing the position to 83,470 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #6114.

Jeff Yass first reported a position in ANRO in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.36M in Q1 2026. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Jeff Yass held 83,470 shares of Alto Neuroscience worth $2.13M as of Q3 2026.
  • Jeff Yass bought 75,472 Alto Neuroscience shares in Q3 2026, an estimated $2.27M.
  • Alto Neuroscience made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6114 holding.
  • Jeff Yass first reported a position in Alto Neuroscience in Q4 2024 and has held it in 8 quarters since.
  • Jeff Yass's Alto Neuroscience position peaked at $5.36M in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.